Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Calgary
The aim is to collect data on prediction, optimization and augmentation of DBS for TRD and develop tools for DBS surgery. It is a biological pilot study designed to provide informative data for future work.
Age
20–70
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
age 20-70
diagnosis of major depressive (MDD)or bipolar disorder(BP)determined independently by 2 study psychiatrists
current major depressive episode of \>1 year duration, treatment-resistant (meaning failure to respond to 4 different classes of antidepressants, including augmentation or combination strategies with lithium, atypical antipsychotics, anticonvulsants, antidepressants, evidence-based psychotherapy, CBT, or electroconvulsive treatment despite adequate dosage, duration and compliance)
minimum score of 20 (out of 52) on the 17 item Hamilton Depression Rating Scale (HDRS)
resident of Alberta, Canada, covered by Alberta Health
You may not be if
other Axis I psychiatric disorders including schizophrenia, psychosis, active suicidal ideation over previous 6 months
cerebrovascular risk factors, previous stroke, head injury and neurodegenerative disorders, pregnancy, medical and general contraindications for DBS surgery (e.g. cardiac pacemaker/defibrillator)
age \>70
diabetes
Clareo Health | DBS for Treatment Resistant Depression
